Limiting glucocorticoid secretion increases the anorexigenic property of Exendin-4
Objective: Glucagon-like peptide-1 (GLP-1) analogs are attractive options for the treatment of type II diabetes and obesity because of their incretin and anorexigenic effects. Peripheral administration of the GLP-1R agonist Exendin-4 (Ex-4) also increases glucocorticoid secretion in rodents and huma...
Saved in:
Main Authors: | Shin J. Lee (Author), Katharina Diener (Author), Sharon Kaufman (Author), Jean-Philippe Krieger (Author), Klaus G. Pettersen (Author), Nino Jejelava (Author), Myrtha Arnold (Author), Alan G. Watts (Author), Wolfgang Langhans (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2016-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Roux-en-Y gastric bypass surgery reprograms enterocyte triglyceride metabolism and postprandial secretion in rats
by: Sharon Kaufman, et al.
Published: (2019) -
Prevalence of the use of anorexigenic drugs by academics of a private institution at Montes Claros-MG
by: Diego Pitangui Guedes de OLIVEIRA, et al.
Published: (2013) -
Loss of dorsomedial hypothalamic GLP-1 signaling reduces BAT thermogenesis and increases adiposity
by: Shin J. Lee, et al.
Published: (2018) -
Comparison of desferrioxamine and NODAGA for the gallium-68 labeling of exendin-4
by: Simon A. M. Kaeppeli, et al.
Published: (2019) -
Exendin-4 effects on islet volume and number in mouse pancreas
by: Layasadat Khorsandi, et al.
Published: (2013)